Literature DB >> 15920024

Can novel therapies for arrhythmias caused by spontaneous sarcoplasmic reticulum Ca2+ release be developed using mouse models?

Steven R Houser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15920024     DOI： 10.1161/01.RES.0000168921.55931.63

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

1.  F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models.

Authors:  B Vacher; C Pignier; R Létienne; Y Verscheure; B Le Grand
Journal:  Br J Pharmacol       Date:  2009-01-07       Impact factor: 8.739

2.  Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

Authors:  L Belardinelli; J C Shryock; H Fraser
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 3.  Update on ranolazine in the management of angina.

Authors:  J Nicolás Codolosa; Subroto Acharjee; Vincent M Figueredo
Journal:  Vasc Health Risk Manag       Date:  2014-06-24

4.  Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias.

Authors:  Bin Liu; Qing Lou; Heather Smith; Florencia Velez-Cortes; Wolfgang H Dillmann; Björn C Knollmann; Antonis A Armoundas; Sándor Györke
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.